Passage Bio Mourns the Sudden Passing of Chairman of the Board Tadataka Yamada, M.D.

NEXT STORY
Valneva Announces Positive Phase 3 Pivotal Results for its Single-Shot Chikungunya Vaccine Candidate
PREV STORY
Imugene and Celularity Announce an Exclusive Strategic Partnership to Develop a Novel Oncolytic Virus – Allogeneic CAR T-Cell Immunotherapy Combination for the Treatment of Solid Tumors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FIT Biotech Oy: FIT Biotech’s cancer patent application published

FIT Biotech Oy  Press release 17.10.2018 at 9.45 EET FIT Biotech's cancer patent application ...

author_avatar
NASDAQ Market News

NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS AT MAY 5, 2017

NUMBER OF SHARES AND VOTING RIGHTS OF Innate Pharma AS AT MAY 5, 2017 ...

author_avatar
NASDAQ Market News

UPDATE: CytomX Announces Time Change for its Presentation at the 35th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...

author_avatar
NASDAQ Market News